228 related articles for article (PubMed ID: 16611950)
1. The effect of telithromycin in acute exacerbations of asthma.
Johnston SL; Blasi F; Black PN; Martin RJ; Farrell DJ; Nieman RB;
N Engl J Med; 2006 Apr; 354(15):1589-600. PubMed ID: 16611950
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
3. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae.
Black PN; Blasi F; Jenkins CR; Scicchitano R; Mills GD; Rubinfeld AR; Ruffin RE; Mullins PR; Dangain J; Cooper BC; David DB; Allegra L
Am J Respir Crit Care Med; 2001 Aug; 164(4):536-41. PubMed ID: 11520711
[TBL] [Abstract][Full Text] [Related]
4. Telithromycin in acute exacerbations of asthma.
Osawa R; Andraws R
N Engl J Med; 2006 Jul; 355(1):97; author reply 97-8. PubMed ID: 16832896
[No Abstract] [Full Text] [Related]
5. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
Medley H; Orozco S; Allen A
Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity.
Busse WW; Casale TB; Dykewicz MS; Meltzer EO; Bird SR; Hustad CM; Grant E; Zeldin RK; Edelman JM
Ann Allergy Asthma Immunol; 2006 Jan; 96(1):60-8. PubMed ID: 16440534
[TBL] [Abstract][Full Text] [Related]
7. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
[TBL] [Abstract][Full Text] [Related]
8. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
[TBL] [Abstract][Full Text] [Related]
9. Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis?
Johnston SL; Martin RJ
Am J Respir Crit Care Med; 2005 Nov; 172(9):1078-89. PubMed ID: 15961690
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults.
Mathers Dunbar L; Hassman J; Tellier G
Clin Ther; 2004 Jan; 26(1):48-62. PubMed ID: 14996517
[TBL] [Abstract][Full Text] [Related]
11. Once-daily evening administration of mometasone furoate in asthma treatment initiation.
Bensch GW; Prenner B; Berkowitz R; Galant S; Ramsdell J; Lutsky B
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):533-40. PubMed ID: 16680923
[TBL] [Abstract][Full Text] [Related]
12. Daily versus as-needed corticosteroids for mild persistent asthma.
Boushey HA; Sorkness CA; King TS; Sullivan SD; Fahy JV; Lazarus SC; Chinchilli VM; Craig TJ; Dimango EA; Deykin A; Fagan JK; Fish JE; Ford JG; Kraft M; Lemanske RF; Leone FT; Martin RJ; Mauger EA; Pesola GR; Peters SP; Rollings NJ; Szefler SJ; Wechsler ME; Israel E;
N Engl J Med; 2005 Apr; 352(15):1519-28. PubMed ID: 15829533
[TBL] [Abstract][Full Text] [Related]
13. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin.
Kraft M; Cassell GH; Pak J; Martin RJ
Chest; 2002 Jun; 121(6):1782-8. PubMed ID: 12065339
[TBL] [Abstract][Full Text] [Related]
14. Five-day telithromycin once daily is as effective as 10-day clarithromycin twice daily for the treatment of acute exacerbations of chronic bronchitis and is associated with reduced health-care resource utilization.
Fogarty C; de Wet R; Mandell L; Chang J; Rangaraju M; Nusrat R
Chest; 2005 Oct; 128(4):1980-8. PubMed ID: 16236845
[TBL] [Abstract][Full Text] [Related]
15. Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations.
Meloni F; Paschetto E; Mangiarotti P; Crepaldi M; Morosini M; Bulgheroni A; Fietta A
J Chemother; 2004 Feb; 16(1):70-6. PubMed ID: 15078002
[TBL] [Abstract][Full Text] [Related]
16. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
Dahl R; Chuchalin A; Gor D; Yoxall S; Sharma R
Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212
[TBL] [Abstract][Full Text] [Related]
17. Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection.
Cosentini R; Tarsia P; Canetta C; Graziadei G; Brambilla AM; Aliberti S; Pappalettera M; Tantardini F; Blasi F
Respir Res; 2008 May; 9(1):48. PubMed ID: 18513407
[TBL] [Abstract][Full Text] [Related]
18. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM; Boulet LP; Follows RM
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[TBL] [Abstract][Full Text] [Related]
19. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms.
Littner MR; Leung FW; Ballard ED; Huang B; Samra NK;
Chest; 2005 Sep; 128(3):1128-35. PubMed ID: 16162697
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
